© Springer Nature Switzerland AG 2021
C. S. Foster et al. (eds.)Uveitishttps://doi.org/10.1007/978-3-030-52974-1_31

31. Brucellosis

Jordan A. Ueberroth1  
(1)
Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA
 
Keywords
BrucellosisUveitis

Overview

  • Definition
    • A zoonotic disease caused by the gram-negative Brucella species transmitted to humans from livestock, causing a flu-like illness with potentially lethal complications of endocarditis or neurobrucellosis
      • Reservoirs include cattle, sheep, goats, and pigs

      • High-risk occupations: abattoirs, veterinarians, animal handlers, and microbiology laboratory workers

    • Uveitis (80%) is the most common ocular manifestation, usually occurring during acute brucellosis

  • Symptoms
    • Blurry vision

    • Floaters

    • Photopsia

  • Laterality
    • Unilateral or bilateral

  • Course
    • Ocular disease occurs in chronic brucellosis and typically resolves after an appropriate course of antimicrobial therapy

  • Age of onset
    • All age groups

  • Gender/race
    • No gender predilection

    • Common in the Mediterranean, Arab gulf, India, Central America and South America, Asia, and sub-Saharan Africa

  • Systemic association
    • Council of State and Territorial Epidemiologists (CSTE) definition: “An illness characterized by acute or insidious onset of fever and one or more of the following: night sweats, arthralgia, headache, fatigue, anorexia, myalgia, weight loss, arthritis/spondylitis, meningitis, or focal organ involvement (endocarditis, orchitis/epididymitis, hepatomegaly, splenomegaly)”

    • Acute brucellosis
      • Average incubation: 1–4 weeks (but highly variable, ranging from 5 days to 6 months)

      • Often subclinical with mild flu-like illness with no sequelae

      • Symptomatic disease presents with fever, anorexia, weight loss, headache, arthralgia, and malaise, with focal organ involvements
        • Musculoskeletal: spondylitis and arthritis, especially of the sacroiliac joints and large joints of the lower extremities, osteomyelitis of the vertebrae, tibia, and especially knee

        • Heart: endocarditis (most common cause of death)

        • Central nervous system (CNS): meningoencephalitis (change in mental status, seizure, coma, neurologic deficits, nuchal rigidity)

        • Gastrointestinal (GI): hepatic abscess, hepatomegaly, splenomegaly

        • Genitourinary: orchitis/epididymitis

        • Pulmonary: multiple syndromes

        • Hematologic: cytopenia, disseminated intravascular coagulation

        • Dermatologic: variable morphologies of rashes

    • Chronic brucellosis (defined as >1 year of symptoms following diagnosis)
      • Can be persistent localized infection (e.g., bone or eye disease) or relapse following treatment

      • Some patients attribute symptoms to chronic brucellosis without objective evidence of infection

Exam: Ocular

Anterior Segment

  • Episcleritis

  • Diffuse or nodular scleritis

  • Nummular keratitis

  • Chronic granulomatous or non-granulomatous iridocyclitis

Posterior Segment

  • Multifocal choroiditis, either in geographic pattern or in circumscribed nodules, is most characteristic of posterior segment disease

  • Vitritis of varying severity

  • Optic disc edema or hyperemia
    • Retrobulbar optic neuritis, chiasmal arachnoiditis

  • Cystoid macular edema

  • Retinal vasculitis

  • Retinitis with edema and hemorrhage

  • Exudative retinal detachment

Exam: Systemic

Findings are variable and nonspecific
  • Hepatosplenomegaly (most common physical finding), lymphadenopathy

  • Right upper quadrant abdominal tenderness

  • Knee swelling, sacroiliac tenderness

  • New or changing murmur (endocarditis), pericardial rub (pericarditis)

  • Nuchal rigidity, Kerning sign, and Brudzinski sign (meningitis)

  • Tender, swollen and erythematous scrotum (orchitis)

Imaging

  • FA
    • Optic nerve staining or leakage

    • Multiple hyperfluorescent lesions with late leakage

  • ICG
    • Multiple hypofluorescent and hyperfluorescent lesions, early

    • Multiple hyperfluorescent spots with associated large areas of hypofluorescence, late

  • Visual field
    • Bilateral blind spot enlargement or visual field constriction

Laboratory and Radiographic Testing

  • Fluid culture for identification of Brucella species (e.g., blood, aqueous, vitreous)

  • Standard agglutination test (SAT)—most commonly used
    • “Gold standard” test that uses an antigen derived from B. abortus to detect both Immunoglobulin G (IgG) and Immunoglobulin M (IgM) agglutinating antibodies

    • Titers exceeding 1:160 are considered significant for brucellosis in endemic areas (1:80 in non-endemic areas)

    • Interpretation of serologies can be challenging in endemic areas and in patients who have been treated previously

    • This test does not detect antibodies to B. canis, which requires B. canis serology for diagnosis

  • Enzyme-linked immunosorbent assay (ELISA)
    • ELISA and SAT both cross-react with other bacteria

    • ELISA and SAT can both give false-negative results early in infection and in immunocompromised patients

  • Polymerase chain reaction (PCR)

  • Anterior chamber tap or vitreous tap with Goldmann-Witmer coefficient analysis

Differential Diagnosis

  • Tuberculosis

  • Syphilis

  • Sarcoidosis

  • White dot syndromes

  • Lyme disease

  • Outer retinal toxoplasmosis

  • Diffuse unilateral subacute neuroretinitis (DUSN)

  • Septic choroiditis

  • Viral retinitis

  • Presumed ocular histoplasmosis syndrome (POHS)

  • Vogt-Koyanagi-Harada (VKH) syndrome

  • Sympathetic ophthalmia

Treatment

  • Adults and children >8 years
    • Oral doxycycline 2–4 mg/kg/day (maximum 200 mg/day) in two divided doses or oral tetracycline 30–40 mg/kg/day (maximum 2000 mg/day) in four divided doses, PLUS

    • Rifampin 15–20 mg/kg/day (max 600–900 mg/day) in one or two divided doses

    • This combination is given for a minimum of 6 weeks

  • Pregnancy patients and children <8 years
    • Oral TMP-SMZ (trimethoprim, 10 mg/kg per day, maximum 480 mg/day; and sulfamethoxazole, 50 mg/kg per day, maximum 2400 mg/day) divided in two doses for 4–6 weeks, OR

    • Rifampin with ceftriaxone

    • TMP-SMZ should be avoided during the last week of pregnancy before delivery due to risk for kernicterus

  • Cases complicated by endocarditis or meningitis
    • Add streptomycin (20–40 mg/kg per day, maximum 1 g/day divided in two doses) or gentamicin (5 mg/kg per day divided in one–three doses) to the above regimen for the first 2 weeks, then extend the regimen for 4–6 months

    • Surgical intervention for deep-tissue abscesses

  • About 10% of patients have relapsing infection despite systemic antimicrobial therapy, due to evasion by intracellular organisms

  • Topical and systemic corticosteroids are appropriate once antimicrobial therapy has been commenced

Referral/Co-management

  • Infectious disease

  • Cardiology

  • Neurology